The utility of emerging fibrosis scoring systems in MASLD: A paradigm shift toward non-invasive, multimodal risk stratification beyond histology.
- DOI
- 10.1055/a-2906-2253
- Published
- 2026 Sep
- Container
- Zeitschrift fur Gastroenterologie
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1055/a-2906-2253,
title = {The utility of emerging fibrosis scoring systems in MASLD: A paradigm shift toward non-invasive, multimodal risk stratification beyond histology.},
author = {Karlas T and Messer EK and Wiegand J},
year = {2026},
journal = {Zeitschrift fur Gastroenterologie},
doi = {10.1055/a-2906-2253},
url = {https://doi.org/10.1055/a-2906-2253}
}RIS
TY - JOUR TI - The utility of emerging fibrosis scoring systems in MASLD: A paradigm shift toward non-invasive, multimodal risk stratification beyond histology. AU - Karlas T AU - Messer EK AU - Wiegand J PY - 2026 JO - Zeitschrift fur Gastroenterologie DO - 10.1055/a-2906-2253 UR - https://doi.org/10.1055/a-2906-2253 ER -
APA
T, K., EK, M., & J, W. (2026). The utility of emerging fibrosis scoring systems in MASLD: A paradigm shift toward non-invasive, multimodal risk stratification beyond histology.. Zeitschrift fur Gastroenterologie. https://doi.org/10.1055/a-2906-2253
Source records
- pubmed · retrieved 2026-09-25T01:49:42.761Z
- europe-pmc · retrieved 2026-09-25T01:49:42.772Z